{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:52:34Z","timestamp":1793145154245,"version":"4.5.0"},"reference-count":736,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amplyx"},{"name":"Arsanis"},{"name":"Astellas"},{"name":"AstraZeneca"},{"name":"Basilea"},{"name":"Bayer","id":[{"id":"https:\/\/ror.org\/04hmn8g73","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010643","name":"Cidara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010643","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"crossref","award":["NIH UM1AI104681"],"award-info":[{"award-number":["NIH UM1AI104681"]}],"id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.cmi.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T13:17:47Z","timestamp":1521379067000},"page":"e1-e38","source":"Crossref","is-referenced-by-count":1407,"special_numbering":"S1","title":["Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline"],"prefix":"10.1016","volume":"24","author":[{"given":"A.J.","family":"Ullmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Warris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Beigelman-Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.M.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Buchheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fortun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Heussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.C.","family":"Kibbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Klimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruhnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sink\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skiada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.G.T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.cmi.2018.01.002_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.cmi.2018.01.002_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1469-0691.12515","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi","volume":"20","author":"Chowdhary","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.cmi.2018.01.002_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1469-0691.12042","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS","volume":"18","author":"Lortholary","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.cmi.2018.01.002_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12037","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"issue":"Suppl. 3","key":"10.1016\/j.cmi.2018.01.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.crad.2012.05.004","article-title":"Commentary on: \"Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation\"","volume":"67","author":"Marchiori","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crad.2012.02.018","article-title":"Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation","volume":"67","author":"Lim","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.beha.2006.11.008","article-title":"New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients","volume":"20","author":"Wingard","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib18","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1080\/13693780500064771","article-title":"The radiological spectrum of pulmonary aspergillosis","volume":"43","author":"Greene","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2214\/ajr.169.5.9353456","article-title":"Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT","volume":"169","author":"Heussel","year":"1997","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.cmi.2018.01.002_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1999.17.3.796","article-title":"Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography","volume":"17","author":"Heussel","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","article-title":"Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery","volume":"15","author":"Caillot","year":"1997","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.cmi.2018.01.002_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2001.tb00010.x","article-title":"Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients","volume":"7","author":"Caillot","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/cid\/cir861","article-title":"Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies","volume":"54","author":"Stanzani","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2214\/ajr.184.3.01840746","article-title":"Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography","volume":"184","author":"Sonnet","year":"2005","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.cmi.2018.01.002_bib27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/jmri.25082","article-title":"Rapid lung MRI in children with pulmonary infections: time to change our diagnostic algorithms","volume":"43","author":"Sodhi","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.cmi.2018.01.002_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/annonc\/mdu192","article-title":"Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"26","author":"Maschmeyer","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00520-007-0346-4","article-title":"Pulmonary MRI\u2014a new approach for the evaluation of febrile neutropenic patients with malignancies","volume":"16","author":"Rieger","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/crj.12061","article-title":"DCE-MRI findings of invasive aspergillosis in patient with acute myeloid leukemia","volume":"8","author":"Araz","year":"2014","journal-title":"Clin Respir J"},{"key":"10.1016\/j.cmi.2018.01.002_bib31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1378\/chest.106.4.1156","article-title":"Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis","volume":"106","author":"Blum","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2018.01.002_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00330-014-3432-2","article-title":"Lung MRI of invasive fungal infection at 3 tesla: evaluation of five different pulse sequences and comparison with multidetector computed tomography (MDCT)","volume":"25","author":"Yan","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","article-title":"Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections","volume":"17","author":"Hot","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib34","first-page":"2999","article-title":"(1)(8)F-FDG-PET\/CT imaging in patients with febrile neutropenia and haematological malignancies","volume":"35","author":"Camus","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cmi.2018.01.002_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.medmal.2013.11.006","article-title":"Diagnosis of invasive pulmonary aspergillosis: updates and recommendations","volume":"44","author":"Desoubeaux","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/RTI.0b013e31805f6a42","article-title":"Comparison of CT features of aspergillus and bacterial pneumonia in severely neutropenic patients","volume":"22","author":"Bruno","year":"2007","journal-title":"J Thorac Imag"},{"key":"10.1016\/j.cmi.2018.01.002_bib37","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/657065","article-title":"Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1439-0507.2002.00770.x","article-title":"The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients","volume":"45","author":"Kami","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1378\/chest.92.1.95","article-title":"Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management","volume":"92","author":"Kuhlman","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2018.01.002_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejrad.2004.03.007","article-title":"Imaging of opportunistic fungal infections in immunocompromised patient","volume":"51","author":"Franquet","year":"2004","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejrad.2005.01.001","article-title":"Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?","volume":"55","author":"Horger","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/01.rti.0000213552.16011.ad","article-title":"Pulmonary invasive aspergillosis and candidiasis in immunocompromised patients: a comparative study of the high-resolution CT findings","volume":"21","author":"Althoff Souza","year":"2006","journal-title":"J Thorac Imag"},{"key":"10.1016\/j.cmi.2018.01.002_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1259\/bjr\/49174919","article-title":"Invasive pulmonary aspergillosis: frequency and meaning of the \"hypodense sign\" on unenhanced CT","volume":"78","author":"Horger","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib45","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.ejrad.2011.03.086","article-title":"The reversed halo sign. Another CT finding useful for distinguish invasive pulmonary aspergillosis and pulmonary lymphoma","volume":"79","author":"Marchiori","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib46","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbmt.2005.03.005","article-title":"Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Kojima","year":"2005","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1148\/radiology.193.2.7972747","article-title":"Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings","volume":"193","author":"Logan","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.cmi.2018.01.002_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/myc.12319","article-title":"Our 2015 approach to invasive pulmonary aspergillosis","volume":"58","author":"Liss","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.201001-0018OC","article-title":"Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial","volume":"182","author":"Azoulay","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00277-007-0391-6","article-title":"Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates","volume":"87","author":"Hummel","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.rmed.2006.04.021","article-title":"Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL","volume":"101","author":"Boersma","year":"2007","journal-title":"Resp Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib52","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.125.2.712","article-title":"Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates","volume":"125","author":"Jain","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2018.01.002_bib54","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.4065\/80.11.1414","article-title":"Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates","volume":"80","author":"Peikert","year":"2005","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.cmi.2018.01.002_bib55","first-page":"961","article-title":"Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray","volume":"85","author":"Ramila","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2141.2003.04308.x","article-title":"Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis","volume":"121","author":"Becker","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.diii.2012.12.008","article-title":"CT-guided biopsies in lung infections in patients with haematological malignancies","volume":"94","author":"de Bazelaire","year":"2013","journal-title":"Diagn Interventi Imaging"},{"key":"10.1016\/j.cmi.2018.01.002_bib58","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/JCM.02387-13","article-title":"Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive aspergillosis enhances diagnostic capabilities","volume":"51","author":"Reinwald","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hon.923","article-title":"CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions","volume":"28","author":"Gupta","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12185-009-0351-0","article-title":"Role of CT-guided percutaneous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases","volume":"89","author":"Shi","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib61","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Florl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib62","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/512812","article-title":"Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens","volume":"44","author":"Rickerts","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11547-006-0004-9","article-title":"Utility of computed tomography (ct) and of fine needle aspiration biopsy (fnab) in early diagnosis of fungal pulmonary infections. Study of infections from filamentous fungi in haematologically immunodeficient patients","volume":"111","author":"Carrafiello","year":"2006","journal-title":"La Radiologia Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib64","first-page":"1405","article-title":"Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies","volume":"88","author":"Nosari","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib65","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/thorax.58.11.920","article-title":"Guidelines for radiologically guided lung biopsy","volume":"58","author":"Manhire","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2018.01.002_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10096-012-1720-9","article-title":"Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses","volume":"32","author":"Georgiadou","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib67","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1399-3046.2007.00733.x","article-title":"Invasive diagnostic procedures for pulmonary infiltrates in pediatric hematopoietic stem cell transplant recipients","volume":"11","author":"Armenian","year":"2007","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.20258","article-title":"Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis","volume":"78","author":"Zihlif","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib69","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2012-02-378976","article-title":"How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation","volume":"120","author":"Wingard","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib70","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3904\/kjim.2013.28.6.660","article-title":"The diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool","volume":"28","author":"Choi","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib71","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1186\/1752-1947-3-9290","article-title":"Diagnosis of invasive aspergillus tracheobronchitis facilitated by endobronchial ultrasound-guided transbronchial needle aspiration: a case report","volume":"3","author":"Casal","year":"2009","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.cmi.2018.01.002_bib72","first-page":"22","article-title":"Coinfection by Nocardia beijingensis and Nocardia arthritidis in an immunocompromised patient diagnosed by endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA)","volume":"12","author":"Aragaki-Nakahodo","year":"2014","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.cmi.2018.01.002_bib73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anorl.2011.06.005","article-title":"Clinical features and outcome of sphenoid sinus aspergillosis: a retrospective series of 15 cases","volume":"129","author":"Thery","year":"2012","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib74","first-page":"821","article-title":"Orbital apex syndrome caused by invasive aspergillosis as an adverse effect of systemic chemotherapy for metastatic colorectal cancer: a case report","volume":"36","author":"Miyamoto","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cmi.2018.01.002_bib75","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jocn.2015.01.012","article-title":"Optic nerve aspergillosis","volume":"22","author":"Yuan","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.cmi.2018.01.002_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152475","article-title":"Magnetic resonance imaging of cerebral aspergillosis: imaging and pathological correlations","volume":"11","author":"Marzolf","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2214\/ajr.162.1.8273655","article-title":"Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings","volume":"162","author":"Ashdown","year":"1994","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.cmi.2018.01.002_bib78","first-page":"1597","article-title":"Disseminated aspergillosis involving the brain: distribution and imaging characteristics","volume":"20","author":"DeLone","year":"1999","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00330-002-1480-5","article-title":"Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview","volume":"13","author":"Guermazi","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib80","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1128\/JCM.37.8.2694-2696.1999","article-title":"Versatile fluorescent staining of fungi in clinical specimens by using the optical brightener blankophor","volume":"37","author":"R\u00fcchel","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/myc.12103","article-title":"Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR","volume":"57","author":"Fraczek","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib82","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/514349","article-title":"Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay","volume":"44","author":"Maertens","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib83","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5603\/AIT.2014.0027","article-title":"Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study","volume":"46","author":"Teering","year":"2014","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.cmi.2018.01.002_bib85","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cir441","article-title":"Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition","volume":"53","author":"Nou\u00e9r","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib86","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","volume":"50","author":"D'Haese","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib87","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/TP.0b013e3181e49bc1","article-title":"Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid","volume":"90","author":"Pasqualotto","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib88","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib90","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-d-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib91","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/myc.12343","article-title":"Diagnostic accuracy of the aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients","volume":"58","author":"Prattes","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib92","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/myc.12424","article-title":"Identification of invasive fungal diseases in immunocompromised patients by combining an aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples","volume":"58","author":"Boch","year":"2015","journal-title":"Mycoses"},{"issue":"10","key":"10.1016\/j.cmi.2018.01.002_bib93","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmi.2016.06.021","volume":"22","author":"Boch","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib94","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/JCM.03322-12","article-title":"Multicenter comparison of serum and whole-blood specimens for detection of aspergillus DNA in high-risk hematological patients","volume":"51","author":"Springer","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib95","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1128\/JCM.02814-15","article-title":"Comparison of performance characteristics of aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations","volume":"54","author":"Springer","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib96","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/JCM.03233-15","article-title":"Comparison of nonculture blood-based tests for diagnosing invasive aspergillosis in an animal model","volume":"54","author":"White","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib97","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of aspergillus PCR for testing serum and plasma: a study by the European aspergillus PCR initiative","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib98","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bjh.12285","article-title":"Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies","volume":"161","author":"Rogers","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib99","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial","volume":"60","author":"Aguado","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: a growing public health concern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4ffcf1da-b180-4149-834c-9c723c5dbf9b","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.cmi.2018.01.002_bib102","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2016.10.019","article-title":"Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the sepia study","volume":"49","author":"Koehler","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib103","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","author":"Van Der Linden","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib104","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrmicro1179","article-title":"Evolution of antifungal-drug resistance: mechanisms and pathogen fitness","volume":"3","author":"Anderson","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib106","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/jac\/dku259","article-title":"Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania","volume":"69","author":"Chowdhary","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib107","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib108","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jiac.2015.04.012","article-title":"First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34\/L98H mutations in Turkey","volume":"21","author":"Ozmerdiven","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib109","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/AAC.02855-14","article-title":"First detection of TR46\/Y121F\/T289A and TR34\/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment","volume":"58","author":"Astvad","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib111","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12281-012-0097-7","article-title":"Azole-resistant invasive aspergillosis: relationship to agriculture","volume":"6","author":"Stensvold","year":"2012","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.cmi.2018.01.002_bib112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ps.3567","article-title":"Environmental fungicides and triazole resistance in aspergillus","volume":"70","author":"Bowyer","year":"2014","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.cmi.2018.01.002_bib113","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib114","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib117","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jac\/dku410","article-title":"Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures","volume":"70","author":"Ahmad","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib118","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/jac\/dkx319","article-title":"Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus","volume":"72","author":"Arendrup","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib119","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib120","first-page":"S94","article-title":"Ketoconazole vs. Itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies","volume":"9","author":"Tricot","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib121","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2141.1999.01465.x","article-title":"A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies","volume":"105","author":"Morgenstern","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib122","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1439-0507.1999.00518.x","article-title":"Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-\u03b2-cyclodextrin oral solution or coated-pellet capsules","volume":"42","author":"Glasmacher","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib123","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1439-0507.1999.00505.x","article-title":"Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole","volume":"42","author":"Glasmacher","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib124","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1200\/JCO.2003.04.052","article-title":"Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients","volume":"21","author":"Glasmacher","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1439-0507.1989.tb02299.x","article-title":"Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels","volume":"32","author":"Boogaerts","year":"1989","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(94)90023-X","article-title":"Niaid mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis","volume":"97","author":"Denning","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib127","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/605499","article-title":"Toxicodynamics of itraconazole: implications for therapeutic drug monitoring","volume":"49","author":"Lestner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/cis437","article-title":"Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections","volume":"55","author":"Pascual","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib130","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib131","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1128\/AAC.01083-10","article-title":"Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients","volume":"55","author":"Troke","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib132","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","article-title":"Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole","volume":"40","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib133","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/AAC.00626-12","article-title":"Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring","volume":"56","author":"Dolton","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib134","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/AAC.00032-15","article-title":"Achieving target voriconazole concentrations more accurately in children and adolescents","volume":"59","author":"Neely","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib135","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1128\/AAC.05761-11","article-title":"Integrated population pharmacokinetic analysis of voriconazole in children, adolescents and adults","volume":"56","author":"Friberg","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib136","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.2010.64","article-title":"Exposure\u2013response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma","volume":"88","author":"Jang","year":"2010","journal-title":"Clin Pharmacol Therapeut"},{"key":"10.1016\/j.cmi.2018.01.002_bib137","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/clpt.2010.261","article-title":"Lack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections","volume":"89","author":"Cornely","year":"2011","journal-title":"Clin Pharmacol Therapeut"},{"key":"10.1016\/j.cmi.2018.01.002_bib138","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib139","series-title":"Assessment report: Noxafil","author":"European Medicine A","year":"2014"},{"issue":"12","key":"10.1016\/j.cmi.2018.01.002_bib140","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/jac\/dkx263","article-title":"Pharmacokinetics and safety results from the phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease","volume":"72","author":"Cornely","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib141","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/jac\/dkw079","article-title":"Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease","volume":"71","author":"Cornely","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib142","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"35","author":"Bowden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib143","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9343(87)90691-7","article-title":"Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis","volume":"83","author":"Stamm","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib144","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jac\/dkl550","article-title":"Flucytosine therapeutic monitoring: 15 years experience from the UK","volume":"59","author":"Pasqualotto","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00156818","article-title":"Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment","volume":"5","author":"Walsh","year":"1989","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib146","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0195-6701(94)90076-0","article-title":"Environmental sampling for aspergilli during building construction on a hospital site","volume":"26","author":"Goodley","year":"1994","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib147","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0950268800067893","article-title":"Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works","volume":"99","author":"Perraud","year":"1987","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib148","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/153.3.634","article-title":"Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction","volume":"153","author":"Opal","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib149","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0195941700067114","article-title":"Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy","volume":"8","author":"Weems","year":"1987","journal-title":"Infect Control"},{"key":"10.1016\/j.cmi.2018.01.002_bib150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/1040841X.2013.777687","article-title":"Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces","volume":"40","author":"Meheust","year":"2014","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib151","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0002-9343(87)90902-8","article-title":"Impact of air filtration on nosocomial aspergillus infections. Unique risk of bone marrow transplant recipients","volume":"83","author":"Sherertz","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib152","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0195-6701(89)90110-2","article-title":"Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation","volume":"14","author":"Barnes","year":"1989","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib153","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1086\/501691","article-title":"Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit","volume":"21","author":"Thio","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib154","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1086\/502101","article-title":"Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies","volume":"23","author":"Hahn","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib155","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/annonc\/mdp034","article-title":"A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients","volume":"20","author":"Maschmeyer","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib156","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/338958","article-title":"Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study","volume":"34","author":"Anaissie","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib157","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/archinte.162.13.1483","article-title":"The hospital water supply as a source of nosocomial infections: a plea for action","volume":"162","author":"Anaissie","year":"2002","journal-title":"Archiv Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib158","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1086\/342305","article-title":"Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized aspergillus species and other opportunistic molds","volume":"35","author":"Anaissie","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib159","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood-2002-02-0530","article-title":"Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies","volume":"101","author":"Anaissie","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajic.2011.03.031","article-title":"Hospital environment and invasive aspergillosis in patients with hematologic malignancy","volume":"40","author":"Lee","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2018.01.002_bib161","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/jhin.2000.0773","article-title":"A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit","volume":"45","author":"Mahieu","year":"2000","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib162","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhin.2011.01.020","article-title":"Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study","volume":"78","author":"R\u00fcping","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib163","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989\u20132003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib164","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3062.2007.00264.x","article-title":"Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey","volume":"10","author":"Sinko","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib166","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib167","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib168","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (path) alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib169","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib171","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (ambiload trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib172","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib173","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (secure): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.01.002_bib174","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1423-0410.2007.00971.x","article-title":"Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions","volume":"93","author":"Ofran","year":"2007","journal-title":"Vox Sang"},{"key":"10.1016\/j.cmi.2018.01.002_bib175","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.21929","article-title":"Recombinant interferon \u03b31b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions","volume":"106","author":"Safdar","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib176","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1537-2995.2006.00996.x","article-title":"Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections","volume":"46","author":"Sachs","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.cmi.2018.01.002_bib177","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cncr.21142","article-title":"Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia","volume":"104","author":"Dignani","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib178","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402007","article-title":"Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections","volume":"15","author":"Lee","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2018.01.002_bib179","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.leu.2400811","article-title":"Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study","volume":"11","author":"Dignani","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2018.01.002_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005341.pub2","article-title":"Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction","author":"Massey","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2018.01.002_bib181","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib182","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-198205000-00003","article-title":"Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes","volume":"61","author":"Pizzo","year":"1982","journal-title":"Medicine (Balt)"},{"key":"10.1016\/j.cmi.2018.01.002_bib183","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib184","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2008.06.040","article-title":"Empirical antifungal therapy for patients with neutropenia and persistent fever: systematic review and meta-analysis","volume":"44","author":"Goldberg","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib185","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib186","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2009.21.8032","article-title":"Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study","volume":"28","author":"Girmenia","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib187","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3324\/haematol.2011.042598","article-title":"The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the hema e-chart project","volume":"96","author":"Pagano","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib188","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib189","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National institute of allergy and infectious diseases mycoses study group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib191","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.03189-12","article-title":"Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis","volume":"51","author":"White","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib192","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib193","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/jac\/dkw299","article-title":"1,3-\u03b2-d-glucan contamination of common antimicrobials-authors' response","volume":"71","author":"Liss","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib194","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkv419","article-title":"1,3-\u03b2-d-glucan contamination of common antimicrobials","volume":"71","author":"Liss","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/myc.12432","article-title":"1,3-\u03b2-d-glucan concentrations in blood products predict false positive post-transfusion results","volume":"59","author":"Liss","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib196","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10096-014-2302-9","article-title":"How to interpret serum levels of \u03b2-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors","volume":"34","author":"Hammarstrom","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib197","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JCM.43.5.2075-2079.2005","article-title":"Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital","volume":"43","author":"Bouza","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib198","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s15010-013-0539-3","article-title":"Simiff study: Italian fungal registry of mold infections in hematological and non-hematological patients","volume":"42","author":"Montagna","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2018.01.002_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120370","article-title":"Causes of death in a contemporary cohort of patients with invasive aspergillosis","volume":"10","author":"Garcia-Vidal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib200","series-title":"Non-construction related Aspergillus outbreak in non-haematological patients related to high concentrations of airborne spores in non-hepa filtered areas","author":"Vena","year":"2015"},{"key":"10.1016\/j.cmi.2018.01.002_bib201","article-title":"Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi","volume":"28","author":"Ruiz-Camps","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.cmi.2018.01.002_bib202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/13693780500488939","article-title":"Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area","volume":"44","author":"Guinea","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib203","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1093\/cid\/cir771","article-title":"Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit","volume":"54","author":"Pelaez","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib204","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-3062.2004.00047.x","article-title":"Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the hepa air filtration system","volume":"6","author":"Munoz","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002813","article-title":"Multiple brain abscesses due to Aspergillus fumigatus in a patient with liver cirrhosis: a case report","volume":"95","author":"Tang","year":"2016","journal-title":"Medicine (Balt)"},{"issue":"8","key":"10.1016\/j.cmi.2018.01.002_bib206","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cmi.2016.05.016","article-title":"New clinical phenotypes of fungal infections in special hosts","volume":"22","author":"Pilmis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib207","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11739-014-1077-4","article-title":"Identification and management of invasive mycoses in internal medicine: a road-map for physicians","volume":"9","author":"Falcone","year":"2014","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jinf.2014.03.018","article-title":"Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors","volume":"69","author":"Peghin","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib209","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (Transnet)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case\u2013control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.cmi.2018.01.002_bib211","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib212","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/13693780600684494","article-title":"Late-onset invasive aspergillosis in organ transplant recipients in the current era","volume":"44","author":"Singh","year":"2006","journal-title":"Med Mycol"},{"issue":"Suppl. 7","key":"10.1016\/j.cmi.2018.01.002_bib213","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12660","article-title":"Invasive fungal infections in solid organ transplant recipients","volume":"20","author":"Gavalda","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib214","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.healun.2013.11.003","article-title":"Invasive aspergillosis among heart transplant recipients: a 24-year perspective","volume":"33","author":"Munoz","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/TP.0b013e31829e6d7b","article-title":"Targeted antifungal prophylaxis in heart transplant recipients","volume":"96","author":"Munoz","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib216","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/lt.24032","article-title":"Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases","volume":"21","author":"Barchiesi","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib217","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/ajt.12963","article-title":"Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients","volume":"14","author":"Winston","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib218","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12041","article-title":"Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation","volume":"56","author":"Lichtenstern","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib219","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00534-011-0423-4","article-title":"The risk factors of fungal infection in living-donor liver transplantations","volume":"19","author":"Ohkubo","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.cmi.2018.01.002_bib220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0b013e3182247bb4","article-title":"Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients","volume":"92","author":"San-Juan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib221","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-6143.2007.02089.x","article-title":"Antifungal management practices in liver transplant recipients","volume":"8","author":"Singh","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib222","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/lt.21099","article-title":"Risk factors for invasive aspergillosis in living donor liver transplant recipients","volume":"13","author":"Osawa","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib223","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-6143.2005.01176.x","article-title":"Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study","volume":"6","author":"Pappas","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib224","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib226","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1600-6143.2009.02635.x","article-title":"Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome","volume":"9","author":"Weigt","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib227","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.resinv.2015.08.005","article-title":"Invasive pulmonary aspergillosis in organ transplants\u2013focus on lung transplants","volume":"54","author":"Geltner","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.cmi.2018.01.002_bib228","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/ajt.13735","article-title":"Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients: results from a multinational matched case\u2013control study","volume":"16","author":"Lopez-Medrano","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib229","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/infdis\/148.2.230","article-title":"Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy","volume":"148","author":"Gustafson","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib230","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/infdis\/jiu636","article-title":"IL1B and DEFB1 polymorphisms increase susceptibility to invasive mold infection after solid-organ transplantation","volume":"211","author":"Wojtowicz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib231","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/cid\/civ386","article-title":"Ptx3 polymorphisms and invasive mold infections after solid organ transplant","volume":"61","author":"Wojtowicz","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib232","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/cid\/civ492","article-title":"Relevance of EORTC criteria for the diagnosis of invasive aspergillosis in HIV-infected patients, and survival trends over a 20-year period in France","volume":"61","author":"Denis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib233","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s15010-002-2033-1","article-title":"Invasive aspergillosis in Italian AIDS patients","volume":"30","author":"Libanore","year":"2002","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2018.01.002_bib234","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s100960000347","article-title":"Role of antiretroviral therapy in long-term survival of patients with AIDS-related pulmonary aspergillosis","volume":"19","author":"Moreno","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00005792-200007000-00008","article-title":"Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review","volume":"79","author":"Mylonakis","year":"2000","journal-title":"Medicine (Balt)"},{"key":"10.1016\/j.cmi.2018.01.002_bib236","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib237","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1600-6143.2012.04142.x","article-title":"Liver retransplantation in HIV-infected patients: a prospective cohort study","volume":"12","author":"Gastaca","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib238","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/lt.22431","article-title":"Epidemiology and outcome of infections in human immunodeficiency virus\/hepatitis C virus-coinfected liver transplant recipients: a FIPSE\/GESIDA prospective cohort study","volume":"18","author":"Moreno","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib239","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0163-4453(98)80164-3","article-title":"Changing role of invasive aspergillosis in aids\u2014a case\u2013control study","volume":"37","author":"Woitas","year":"1998","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9343(93)90258-Q","article-title":"Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French cooperative study group on aspergillosis in AIDS","volume":"95","author":"Lortholary","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib241","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJM199103073241003","article-title":"Pulmonary aspergillosis in the acquired immunodeficiency syndrome","volume":"324","author":"Denning","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib242","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1309\/AJCPRAAE8LZ7DTNE","article-title":"Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002","volume":"132","author":"Antinori","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-6958-9-1","article-title":"Clinical findings in 19 cases of invasive pulmonary aspergillosis with liver cirrhosis","volume":"9","author":"Chen","year":"2014","journal-title":"Multidiscip Resp Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib244","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2143\/ACB.3408","article-title":"Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years","volume":"68","author":"Jeurissen","year":"2013","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.cmi.2018.01.002_bib245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","article-title":"Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality","volume":"59","author":"Vandewoude","year":"2004","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.cmi.2018.01.002_bib246","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.mcg.0000248018.08515.f9","article-title":"Infections in patients with end-stage liver disease","volume":"41","author":"Cheruvattath","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cmi.2018.01.002_bib247","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","author":"Falcone","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib248","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diagmicrobio.2014.05.015","article-title":"Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?","volume":"80","author":"Russo","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib249","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-015-1140-1","article-title":"Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study","volume":"19","author":"Delsuc","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006\u20132008)","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib251","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jinf.2009.11.005","article-title":"Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity","volume":"60","author":"Jensen","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib252","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1017\/S0950268811002603","article-title":"Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients","volume":"140","author":"Vehreschild","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib253","doi-asserted-by":"crossref","first-page":"R1919","DOI":"10.1186\/cc3488","article-title":"Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome","volume":"9","author":"Garnacho-Montero","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib254","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QCO.0000000000000043","article-title":"Approach to invasive pulmonary aspergillosis in critically ill patients","volume":"27","author":"Koulenti","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib255","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13054-014-0458-4","article-title":"How to manage aspergillosis in non-neutropenic intensive care unit patients","volume":"18","author":"Bassetti","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib256","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2012.06805.x","article-title":"Invasive aspergillosis in the intensive care unit","volume":"1272","author":"Dimopoulos","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cmi.2018.01.002_bib257","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib258","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2049-6958-8-59","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"8","author":"Tutar","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib259","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/myc.12045","article-title":"Growth of Aspergillus in blood cultures: proof of invasive aspergillosis in patients with chronic obstructive pulmonary disease?","volume":"56","author":"Giannella","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.riam.2011.06.006","article-title":"Cardiac invasive aspergillosis in a heart transplant recipient","volume":"28","author":"Eworo","year":"2011","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.cmi.2018.01.002_bib261","doi-asserted-by":"crossref","first-page":"468","DOI":"10.14503\/THIJ-14-4732","article-title":"Aspergillus mediastinitis after orthotopic heart transplantation: a case report","volume":"42","author":"El-Sayed Ahmed","year":"2015","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cmi.2018.01.002_bib262","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1055\/s-0034-1366647","article-title":"Invasive cardiac aspergillosis after orthotopic liver transplantation","volume":"52","author":"Wiltberger","year":"2014","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.cmi.2018.01.002_bib263","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijantimicag.2013.10.012","article-title":"Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the ASPICU cohort","volume":"43","author":"Spapen","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.01.002_bib264","first-page":"229","article-title":"Mold infections in lung transplants","volume":"31","author":"Sole","year":"2014","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.cmi.2018.01.002_bib265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eimc.2011.12.005","article-title":"Aspergillosis. Clinical forms and treatment","volume":"30","author":"Fortun","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.cmi.2018.01.002_bib266","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/lt.21587","article-title":"Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens","volume":"14","author":"Singh","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib267","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3109\/00365548.2012.705018","article-title":"Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome","volume":"44","author":"Shields","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib268","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","article-title":"The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis","volume":"33","author":"Perfect","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib269","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(97)89455-7","article-title":"The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis","volume":"100","author":"Horvath","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib270","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/mmy\/myu090","article-title":"Sputum and bronchial secretion samples are equally useful as bronchoalveolar lavage samples for the diagnosis of invasive pulmonary aspergillosis in selected patients","volume":"53","author":"Escribano","year":"2015","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib271","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.TP.0000044358.99414.B8","article-title":"The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis","volume":"75","author":"Munoz","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib272","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10096-013-1827-7","article-title":"Assessment of the significance of respiratory culture of aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria","volume":"32","author":"Barton","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib273","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s00330-004-2447-5","article-title":"Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist","volume":"14","author":"Zaspel","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib274","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2014.05.003","article-title":"Invasive pulmonary aspergillosis in heart transplant recipients: two radiologic patterns with a different prognosis","volume":"33","author":"Munoz","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib276","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/cc10138","article-title":"Diagnosis of invasive bronchial-pulmonary aspergillosis in patients with chronic obstructive respiratory diseases","volume":"15","author":"Bulpa","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib277","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1097\/TP.0000000000000763","article-title":"Performance characteristics of galactomannan and \u03b2-d-glucan in high-risk liver transplant recipients","volume":"99","author":"Singh","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib278","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061545","article-title":"Evaluation of mycassay Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer","volume":"8","author":"Guinea","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib279","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jcla.21580","article-title":"Incidence of pulmonary aspergillosis and correlation of conventional diagnostic methods with nested PCR and real-time PCR assay using bal fluid in intensive care unit patients","volume":"27","author":"Zarrinfar","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.cmi.2018.01.002_bib280","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JCM.03216-14","article-title":"Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid","volume":"53","author":"Chong","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib281","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jinf.2016.02.019","article-title":"Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients","volume":"72","author":"Fortun","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib282","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/TP.0b013e31819288d5","article-title":"False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib283","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2169\/internalmedicine.53.2381","article-title":"Diagnostic value of the serum galactomannan and (1, 3)- \u03b2-d-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"53","author":"Cai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib284","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","article-title":"Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"19","author":"Eigl","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib285","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","article-title":"Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases","volume":"190","author":"Prattes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.cmi.2018.01.002_bib286","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/ajt.13837","article-title":"Clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study","volume":"16","author":"Lopez-Medrano","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib287","doi-asserted-by":"crossref","first-page":"482","DOI":"10.6002\/ect.2012.0028","article-title":"Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature","volume":"10","author":"Cherian","year":"2012","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib288","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3111\/13696998.2011.564246","article-title":"Us hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host","volume":"14","author":"Patel","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.cmi.2018.01.002_bib289","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000202421.94822.f7","article-title":"Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study","volume":"81","author":"Singh","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib290","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2012.04042.x","article-title":"Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients","volume":"12","author":"Luong","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib291","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/tid.12389","article-title":"Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole","volume":"17","author":"Shoham","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib292","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.00251-13","article-title":"Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies","volume":"57","author":"Hoenigl","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.cmi.2018.01.002_bib293","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/myc.12517","article-title":"Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether \u03b2-cyclodextrin in haematological patients with renal impairment","volume":"59","author":"Kim","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib294","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/mmy\/myv099","article-title":"Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels","volume":"54","author":"Guinea","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib295","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1128\/AAC.03641-14","article-title":"Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients","volume":"58","author":"Vanstraelen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib296","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/jac\/dku528","article-title":"Rate of cyp51a mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis","volume":"70","author":"Shalhoub","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib297","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/AAC.02487-12","article-title":"Is azole resistance in Aspergillus fumigatus a problem in Spain?","volume":"57","author":"Escribano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib298","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","author":"Fuhren","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib299","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/TP.0b013e31825992f0","article-title":"Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis","volume":"94","author":"Egli","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib300","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.01544-10","article-title":"Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole","volume":"55","author":"Kuipers","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib301","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trim.2013.09.007","article-title":"Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis","volume":"29","author":"Singh","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.cmi.2018.01.002_bib302","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/QCO.0b013e3283630e67","article-title":"Is universal antifungal prophylaxis mandatory in lung transplant patients?","volume":"26","author":"Schaenman","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib303","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/00365548.2012.691207","article-title":"Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients","volume":"44","author":"Tofte","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib304","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.cmi.2018.01.002_bib305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/TP.0b013e318255f864","article-title":"A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis","volume":"94","author":"Koo","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib306","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1399-0012.2011.01405.x","article-title":"Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety","volume":"26","author":"Munoz","year":"2012","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib307","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tid.12337","article-title":"Practice variation in aspergillus prophylaxis and treatment among lung transplant centers: a national survey","volume":"17","author":"He","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib308","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/ciu1128","article-title":"Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients","volume":"60","author":"Saliba","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib309","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.cmi.2018.01.002_bib310","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/TP.0000000000001050","article-title":"Antifungal prophylaxis in lung transplant recipients","volume":"100","author":"Patel","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib311","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/lt.24391","article-title":"Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: a propensity score analysis","volume":"22","author":"Fortun","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib312","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/tid.12187","article-title":"Itraconazole prophylaxis for invasive aspergillus infection in lung transplantation","volume":"16","author":"Kato","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib313","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/lt.24365","article-title":"Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients","volume":"22","author":"Balogh","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib314","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/lt.23410","article-title":"Safety of anidulafungin in solid organ transplant recipients","volume":"18","author":"Aguado","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib315","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib316","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02013825","article-title":"CT of invasive pulmonary aspergillosis in children with cancer","volume":"23","author":"Taccone","year":"1993","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib317","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00006454-200101000-00002","article-title":"Computed tomography in the evaluation of febrile neutropenic pediatric oncology patients","volume":"20","author":"Archibald","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib318","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2018.01.002_bib319","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pbc.20717","article-title":"Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders","volume":"48","author":"Hovi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib321","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/INF.0b013e3180616cbb","article-title":"Prospective aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients","volume":"26","author":"Steinbach","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib322","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/INF.0b013e31817197ab","article-title":"Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis","volume":"27","author":"Hayden","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib323","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1469-0691.2009.03065.x","article-title":"Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation","volume":"16","author":"Castagnola","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib324","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jpids\/pis044","article-title":"Galactomannan antigen testing for diagnosis of invasive aspergillosis in pediatric hematology patients","volume":"1","author":"Fisher","year":"2012","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.cmi.2018.01.002_bib325","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pbc.24363","article-title":"Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients","volume":"60","author":"Choi","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib326","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/myc.12048","article-title":"Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies","volume":"56","author":"Jha","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib327","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jmii.2013.12.003","article-title":"Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children","volume":"49","author":"Dinand","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib328","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00025-07","article-title":"Quantification of 1,3-\u03b2-d-glucan levels in children: preliminary data for diagnostic use of the \u03b2-glucan assay in a pediatric setting","volume":"14","author":"Smith","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2018.01.002_bib329","first-page":"905","article-title":"Value of plasma \u03b2-glucan in early diagnosis of invasive fungal infection in children","volume":"11","author":"Zhao","year":"2009","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.cmi.2018.01.002_bib330","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CVI.00038-10","article-title":"High levels of \u03b2-d-glucan in immunocompromised children with proven invasive fungal disease","volume":"17","author":"Mularoni","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2018.01.002_bib331","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and \u03b2-d-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.cmi.2018.01.002_bib332","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/JCM.00747-15","article-title":"\u03b2-d-glucan screening for detection of invasive fungal disease in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"53","author":"Koltze","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib333","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib334","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib335","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib336","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.leu.2405065","article-title":"Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin","volume":"22","author":"Raad","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cmi.2018.01.002_bib337","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jac\/dkp397","article-title":"Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B","volume":"65","author":"Cornely","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib338","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2010.04.017","article-title":"Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients","volume":"17","author":"Winston","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib339","first-page":"64","article-title":"Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles","volume":"26","author":"De la Serna","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.cmi.2018.01.002_bib340","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib341","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.2174\/1381612811319200010","article-title":"Immunotherapy in invasive fungal infection\u2014focus on invasive aspergillosis","volume":"19","author":"Lehrnbecher","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.cmi.2018.01.002_bib342","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.1997.2473063.x","article-title":"A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients","volume":"98","author":"Prentice","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib343","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":"A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia","volume":"29","author":"Maertens","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib344","doi-asserted-by":"crossref","DOI":"10.4081\/pr.2012.e2","article-title":"Empiric antibiotic therapy in a child with cancer and suspected septicemia","volume":"4","author":"Caselli","year":"2012","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.cmi.2018.01.002_bib345","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"Tan","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib346","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/INF.0000000000000101","article-title":"Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience","volume":"33","author":"Castagnola","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib349","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.cmi.2018.01.002_bib350","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00330-016-4717-4","article-title":"Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis","volume":"27","author":"Vehreschild","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib351","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/587101","article-title":"When primary antifungal therapy fails","volume":"46","author":"Nucci","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 6","key":"10.1016\/j.cmi.2018.01.002_bib352","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1086\/430921","article-title":"Salvage therapy for aspergillosis","volume":"41","author":"Bennett","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib353","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/JCM.00750-11","article-title":"Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients","volume":"50","author":"Bergeron","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib354","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24022","article-title":"Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients","volume":"115","author":"Maertens","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib355","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/339324","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease","volume":"34","author":"Boutboul","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib356","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib357","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/508455","article-title":"Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection","volume":"43","author":"Almyroudis","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib358","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2018.01.002_bib359","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02520-2016","article-title":"Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis","volume":"49","author":"Salzer","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2018.01.002_bib360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12890-016-0276-3","article-title":"Aspergillus nodules; another presentation of chronic pulmonary aspergillosis","volume":"16","author":"Muldoon","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib361","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/myc.12589","article-title":"Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID\/ERS\/ECMM and IDSA guidelines","volume":"60","author":"Salzer","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib362","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/JCM.03261-15","article-title":"Prospective evaluation of a new aspergillus IgG enzyme immunoassay kit for diagnosis of chronic and allergic pulmonary aspergillosis","volume":"54","author":"Dumollard","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib363","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1749-8090-8-180","article-title":"Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence\u2013a national centre's experience","volume":"8","author":"Farid","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cmi.2018.01.002_bib364","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"Cadranel","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib365","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis","volume":"57","author":"Al-Shair","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib366","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0720-048X(92)90059-I","article-title":"Invasive aspergillosis in immunocompromised patients: findings on plain film and (hr)CT","volume":"14","author":"Pasmans","year":"1992","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib367","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s003300050157","article-title":"Aneurysms complicating inflammatory diseases in immunocompromised hosts: value of contrast-enhanced CT","volume":"7","author":"Heussel","year":"1997","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib368","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1164\/rccm.201310-1780IM","article-title":"Pulmonary arterial mycotic pseudoaneurysms in a patient with invasive pulmonary aspergillosis. Successful occlusion by coils","volume":"190","author":"Didier","year":"2014","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib369","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1473-3099(03)00580-2","article-title":"British society for medical mycology proposed standards of care for patients with invasive fungal infections","volume":"3","author":"Denning","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib370","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/jclinpath-2011-200500","article-title":"From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification?","volume":"65","author":"Vyzantiadis","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib371","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1309\/DK1CG9MATKYYBFMQ","article-title":"Immunohistochemical detection of Aspergillus species in pediatric tissue samples","volume":"121","author":"Choi","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib372","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/jcm.35.9.2206-2209.1997","article-title":"Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies","volume":"35","author":"Kaufman","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib373","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.49.10.798","article-title":"Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections","volume":"49","author":"Verweij","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib374","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00019606-200303000-00003","article-title":"In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section","volume":"12","author":"Hayden","year":"2003","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib375","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2559.2006.02515.x","article-title":"Pathology of fungal infections of the central nervous system: 17 years' experience from southern India","volume":"49","author":"Sundaram","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.cmi.2018.01.002_bib376","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1439-0507.1993.tb00758.x","article-title":"Evaluation of calcofluor staining in the diagnosis of fungal corneal ulcer","volume":"36","author":"Chander","year":"1993","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib377","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mimet.2011.01.024","article-title":"Homogenisation of cystic fibrosis sputum by sonication\u2014an essential step for Aspergillus PCR","volume":"85","author":"Baxter","year":"2011","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.cmi.2018.01.002_bib378","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/jac\/dkq438","article-title":"Detection and investigation of invasive mould disease","volume":"66","author":"Cuenca-Estrella","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib379","doi-asserted-by":"crossref","first-page":"610","DOI":"10.12968\/hosp.2000.61.9.1416","article-title":"Clinical and laboratory diagnosis","volume":"61","author":"Richardson","year":"2000","journal-title":"Hosp Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib380","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1469-0691.2010.03323.x","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species","volume":"17","author":"Alanio","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib381","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1469-0691.2011.03688.x","article-title":"Maldi-tof ms andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures","volume":"18","author":"Bille","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib382","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1128\/JCM.00224-12","article-title":"Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species","volume":"50","author":"De Carolis","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib383","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/JCM.02852-12","article-title":"Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"51","author":"Lau","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib384","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/JCM.01685-08","article-title":"Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here?","volume":"47","author":"Balajee","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib385","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3114\/sim.2007.59.14","article-title":"Polyphasic taxonomy of Aspergillus section fumigati and its teleomorph neosartorya","volume":"59","author":"Samson","year":"2007","journal-title":"Stud Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib386","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075968","article-title":"Snapafu: a novel single nucleotide polymorphism multiplex assay for Aspergillus fumigatus direct detection, identification and genotyping in clinical specimens","volume":"8","author":"Caramalho","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib387","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/JCM.00124-09","article-title":"Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus","volume":"47","author":"Hurst","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib388","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/JCM.01159-11","article-title":"Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis","volume":"49","author":"Guinea","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib389","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1469-0691.12323","article-title":"Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis","volume":"20","author":"Rougeron","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib390","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1086\/343804","article-title":"Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients","volume":"186","author":"Maertens","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib391","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"4","author":"Leeflang","year":"2008","journal-title":"Cochrane Collab"},{"key":"10.1016\/j.cmi.2018.01.002_bib392","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1111\/j.1399-3062.2012.00733.x","article-title":"Galactomannan: testing the same sample twice?","volume":"14","author":"Furfaro","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib393","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial","volume":"13","author":"Morrissey","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib394","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib395","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/myc.12060","article-title":"Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy","volume":"56","author":"Hoenigl","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib396","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib397","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib398","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib399","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13693780801978968","article-title":"Value of a single galactomannan determination (platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp","volume":"46","author":"Guinea","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib400","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1600-6143.2004.00415.x","article-title":"Prospective assessment of platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients","volume":"4","author":"Husain","year":"2004","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib401","doi-asserted-by":"crossref","first-page":"278","DOI":"10.6002\/ect.2011.0176","article-title":"Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients","volume":"10","author":"Tabarsi","year":"2012","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib402","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMc1210430","article-title":"False positive galactomannan test after ice-pop ingestion","volume":"369","author":"Guigue","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib403","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JCM.05031-11","article-title":"Galactomannan antigenemia after infusion of gluconate-containing plasma-lyte","volume":"49","author":"Petraitiene","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib404","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1093\/cid\/cis493","article-title":"False-positive aspergillus antigenemia due to blood product conditioning fluids","volume":"5","author":"Martin-Rabadan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib405","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/jac\/dks111","article-title":"Piperacillin\/tazobactam (tazocintm) seems to be no longer responsible for false-positive results of the galactomannan assay","volume":"67","author":"Mikulska","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib406","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2011.00675.x","article-title":"False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis","volume":"14","author":"Vergidis","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib407","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JCM.00050-07","article-title":"Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus","volume":"45","author":"Huang","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib408","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087784","article-title":"Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing","volume":"9","author":"Nucci","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib409","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/cid\/cit783","article-title":"Considering confounders of the galactomannan index: the role of piperacillin-tazobactam","volume":"58","author":"King","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib410","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JCM.06513-11","article-title":"Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis","volume":"50","author":"Chai","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib411","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0609.2012.01806.x","article-title":"Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan elisa in bronchoalveolar lavage sample","volume":"89","author":"Reinwald","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib412","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib413","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib414","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cit393","article-title":"The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"57","author":"Fisher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib415","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/JCM.37.4.1186-1189.1999","article-title":"Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management","volume":"37","author":"Verweij","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib416","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/JCM.40.4.1496-1499.2002","article-title":"Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis","volume":"40","author":"Viscoli","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib417","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/425317","article-title":"Utility of Aspergillus antigen detection in specimens other than serum specimens","volume":"39","author":"Klont","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib418","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","article-title":"Diagnosis of invasive fungal disease using serum (1-3)- \u03b2-d-glucan: a bivariate meta-analysis","volume":"50","author":"Lu","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib419","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib420","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/527382","article-title":"1,3-\u03b2-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia","volume":"46","author":"Senn","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib421","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/jmm.0.47479-0","article-title":"Assessment of the clinical utility of serial \u03b2-d-glucan concentrations in patients with persistent neutropenic fever","volume":"57","author":"Ellis","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib422","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","article-title":"Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1\u21923)- \u03b2-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib423","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"\u03b2-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib424","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) \u03b2-d-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib425","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"\u03b2-d-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib426","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1128\/CVI.05408-11","article-title":"Clinical performance of the (1,3)- \u03b2-d-glucan assay in early diagnosis of nosocomial Candida bloodstream infections","volume":"18","author":"Del Bono","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2018.01.002_bib427","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10096-011-1365-0","article-title":"Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)- \u03b2-d-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease","volume":"31","author":"Acosta","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib428","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2012.10.003","article-title":"Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients","volume":"65","author":"Hoenigl","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib429","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s15010-013-0472-5","article-title":"Comparison of a novel Aspergillus lateral-flow device and the platelia\u00a9 galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation","volume":"41","author":"Held","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2018.01.002_bib430","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, \u03b2-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib431","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(05)61265-2","article-title":"Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation","volume":"352","author":"Einsele","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.01.002_bib432","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1164\/ajrccm\/148.5.1313","article-title":"The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid","volume":"148","author":"Tang","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib433","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1128\/jcm.33.12.3150-3153.1995","article-title":"Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies","volume":"33","author":"Verweij","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib434","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1128\/jcm.33.5.1164-1168.1995","article-title":"Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR","volume":"33","author":"Bretagne","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib435","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jcp.51.9.652","article-title":"PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients","volume":"51","author":"Jones","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib436","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1128\/JCM.37.12.3865-3871.1999","article-title":"Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR","volume":"37","author":"Skladny","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib437","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/321887","article-title":"Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results","volume":"33","author":"Buchheidt","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib438","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1128\/JCM.39.6.2338-2340.2001","article-title":"Detection of aspergillus species DNA by PCR in bronchoalveolar lavage fluid","volume":"39","author":"Hayette","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib439","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/jcm.32.7.1710-1717.1994","article-title":"General primer-mediated PCR for detection of Aspergillus species","volume":"32","author":"Melchers","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib440","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.0007-1048.2002.03337.x","article-title":"Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients","volume":"116","author":"Buchheidt","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib441","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1378\/chest.121.4.1171","article-title":"Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL","volume":"121","author":"Raad","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2018.01.002_bib442","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/JCM.41.5.1811-1818.2003","article-title":"Development of a lightcycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients","volume":"41","author":"Spiess","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib443","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/mmy.41.1.65.74","article-title":"Evaluation of a polymerase chain reaction reverse hybridization line probe assay for the detection and identification of medically important fungi in bronchoalveolar lavage fluids","volume":"41","author":"Meltiadis","year":"2003","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib444","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1128\/JCM.41.8.3922-3925.2003","article-title":"Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis","volume":"41","author":"Sanguinetti","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib445","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1128\/JCM.41.9.4304-4311.2003","article-title":"Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis","volume":"41","author":"Rantakokko-Jalava","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib446","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/JCM.42.9.4154-4157.2004","article-title":"Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples","volume":"42","author":"Lass-Fl\u00f6rl","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib447","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1128\/JCM.42.12.5517-5522.2004","article-title":"Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid","volume":"42","author":"Musher","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib448","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-8-73","article-title":"Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid","volume":"8","author":"Khot","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib449","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10096-008-0616-1","article-title":"Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance","volume":"28","author":"Fr\u00e9alle","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib450","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1128\/JCM.05026-11","article-title":"Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay","volume":"49","author":"Torelli","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib451","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2334-12-237","article-title":"Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients","volume":"12","author":"Buess","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib452","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/jac\/dks208","article-title":"Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies","volume":"67","author":"Reinwald","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib453","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diagmicrobio.2012.03.001","article-title":"Performance of 2 commercial real-time polymerase chain reaction assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patients","volume":"73","author":"Orsi","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib454","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061545","article-title":"Evaluation of mycassayt Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer","volume":"8","author":"Guinea","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib455","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-3062.2009.00367.x","article-title":"Invasive aspergillosis in two liver transplant recipients: diagnosis by septifast","volume":"11","author":"Steinmann","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib456","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00043426-200401000-00013","article-title":"Molecular diagnosis of cerebral aspergillosis by sequence analysis with panfungal polymerase chain reaction","volume":"26","author":"Komatsu","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib457","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2169\/internalmedicine.38.45","article-title":"Early diagnosis of central nervous system aspergillosis with combination use of cerebral diffusion-weighted echo-planar magnetic resonance image and polymerase chain reaction of cerebrospinal fluid","volume":"38","author":"Kami","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib458","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1128\/JCM.00466-06","article-title":"Detection of aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay","volume":"44","author":"Hummel","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib459","first-page":"381","article-title":"Assessment of a real-time PCR method to detect human non-cryptococcal fungal meningitis","volume":"14","author":"Badiee","year":"2011","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib461","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JCM.05316-11","article-title":"Evaluation of Aspergillus PCR protocols for testing serum specimens","volume":"49","author":"White","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib462","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/499949","article-title":"The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting","volume":"42","author":"White","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib463","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/JCM.02965-12","article-title":"Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study","volume":"51","author":"Lass-Fl\u00f6rl","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib464","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/mp.56.6.368","article-title":"Development of molecular methods for the identification of Aspergillus and emerging moulds in paraffin wax embedded tissue sections","volume":"56","author":"Paterson","year":"2003","journal-title":"Mol Pathol"},{"key":"10.1016\/j.cmi.2018.01.002_bib465","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1086\/498111","article-title":"Validation and clinical application of molecular methods for the identification of molds in tissue","volume":"42","author":"Paterson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib466","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000196477","article-title":"Pulmonary aspergillosis: early diagnosis improves survival","volume":"62","author":"von Eiff","year":"1995","journal-title":"Respiration"},{"key":"10.1016\/j.cmi.2018.01.002_bib467","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1439-0507.2004.01035.x","article-title":"Antibody detection in patients with invasive aspergillosis","volume":"47","author":"Kappe","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib468","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/JCM.39.5.1721-1730.2001","article-title":"Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases","volume":"39","author":"Weig","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib469","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.bbmt.2012.07.013","article-title":"Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis","volume":"18","author":"Du","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib470","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/141.5.656","article-title":"Serologic immunodiagnosis of of invasive aspergillosis","volume":"141","author":"Holmberg","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib471","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/BF02276061","article-title":"Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies","volume":"13","author":"Manso","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib472","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/jcm.17.4.708-710.1983","article-title":"Efficacy of enzyme-linked immunosorbent assay in serodiagnosis of aspergillosis","volume":"17","author":"Mishra","year":"1983","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib473","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1439-0507.1996.tb00078.x","article-title":"Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis","volume":"39","author":"Kappe","year":"1996","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib474","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The CDR1b efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib475","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib476","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010080","article-title":"Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence","volume":"5","author":"Arendrup","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib477","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/597465","article-title":"Azole-resistant central nervous system aspergillosis","volume":"48","author":"van der Linden","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib478","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with tr34\/l98h mutations in the cyp51a gene in Iran","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib479","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052871","article-title":"Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the tr(3)(4)\/l98h mutations in the cyp51a gene in India","volume":"7","author":"Chowdhary","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib480","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib481","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp","volume":"16","author":"Arendrup","year":"2013","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2018.01.002_bib482","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.48.20326-en","article-title":"Azole-resistant Aspergillus fumigatus due to tr46\/y121f\/t289a mutation emerging in Belgium, July 2012","volume":"17","author":"Vermeulen","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2018.01.002_bib483","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the tr\/l98h mutations in the cyp51a gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib484","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/AAC.01017-12","article-title":"First reported case of azole-resistant Aspergillus fumigatus due to the tr\/l98h mutation in Germany","volume":"56","author":"Rath","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib485","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/EC.00272-08","article-title":"Aspergillus alabamensis, a new clinically relevant species in the section terrei","volume":"8","author":"Balajee","year":"2009","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.cmi.2018.01.002_bib486","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01250-17","article-title":"Single-center evaluation of an agar-based screening for azole resistance in Aspergillus fumigatus by using vipcheck","volume":"61","author":"Buil","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib487","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0140-6736(07)61055-1","article-title":"Aspergillosis\u2014and a misleading sensitivity result","volume":"370","author":"van Leer-Buter","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2018.01.002_bib488","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/myc.12047","article-title":"Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis","volume":"56","author":"Howard","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib489","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1111\/1469-0691.12148","article-title":"EUCAST technical note on voriconazole and Aspergillus spp","volume":"19","author":"Hope","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib490","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.01.017","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents","volume":"22","author":"Arendrup","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib491","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard","author":"Rex","year":"2008"},{"key":"10.1016\/j.cmi.2018.01.002_bib492","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib493","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1128\/AAC.00862-09","article-title":"Comparison of assessment of oxygen consumption, Etest, and CLSI m38-a2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole","volume":"53","author":"Araujo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib494","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13693780801975576","article-title":"Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus","volume":"46","author":"Arikan","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib495","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.01512-07","article-title":"In vitro antifungal activities of isavuconazole (bal4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species","volume":"52","author":"Guinea","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib496","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","article-title":"Cryptic species and azole resistance in the Aspergillus niger complex","volume":"55","author":"Howard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib497","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/40.3.401","article-title":"Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection","volume":"40","author":"Denning","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib498","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib499","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.diagmicrobio.2011.08.006","article-title":"In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"71","author":"Rudramurthy","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib500","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib501","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib502","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/AAC.01530-08","article-title":"In vitro activity of isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"53","author":"Perkhofer","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib503","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib504","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51a gene","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib505","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/AAC.00636-13","article-title":"Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. For the CLSI m38-a2 broth microdilution method","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib506","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1128\/AAC.01111-13","article-title":"Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method","volume":"57","author":"Howard","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib507","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1128\/AAC.01141-13","article-title":"In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole","volume":"57","author":"Gregson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib508","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1592\/phco.2005.25.9.1174","article-title":"Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy","volume":"25","author":"Lionakis","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2018.01.002_bib509","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1128\/AAC.45.5.1456-1462.2001","article-title":"Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo","volume":"45","author":"Mosquera","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib510","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/jac\/dkt232","article-title":"Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis","volume":"68","author":"Barchiesi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib511","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3109\/13693786.2012.684154","article-title":"Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection","volume":"50","author":"Hadrich","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib512","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"Eucast technical note on aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib513","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Available at: http:\/\/www.eucast.org."},{"key":"10.1016\/j.cmi.2018.01.002_bib514","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. For the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib515","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib516","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib517","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a seifem-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib518","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib519","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib520","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijantimicag.2010.08.010","article-title":"The nationwide austrian aspergillus registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and\/or immunosuppressed patients","volume":"36","author":"Perkhofer","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.01.002_bib521","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.00335-08","article-title":"In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"53","author":"Lass-Florl","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib522","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118997","article-title":"Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing","volume":"10","author":"Kathuria","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib523","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","article-title":"In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus","volume":"48","author":"Alastruey-Izquierdo","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib524","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/AAC.00942-07","article-title":"Aspergillus section fumigati: antifungal susceptibility patterns and sequence-based identification","volume":"52","author":"Alcazar-Fuoli","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib525","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/JCM.01190-13","article-title":"Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility","volume":"51","author":"Datta","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib526","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11046-014-9774-0","article-title":"Multi-resistant aspergillosis due to cryptic species","volume":"178","author":"Howard","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2018.01.002_bib527","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/QCO.0b013e328358b0a4","article-title":"Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management","volume":"25","author":"Falcone","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib528","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-199809000-00004","article-title":"Aspergillus nidulans infection in chronic granulomatous disease","volume":"77","author":"Segal","year":"1998","journal-title":"Medicine (Balt)"},{"key":"10.1016\/j.cmi.2018.01.002_bib529","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","article-title":"Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis","volume":"68","author":"Seyedmousavi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib530","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drup.2014.06.001","article-title":"The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside","volume":"17","author":"Seyedmousavi","year":"2014","journal-title":"Drug Resist Updat"},{"issue":"5","key":"10.1016\/j.cmi.2018.01.002_bib531","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jinf.2016.06.001","article-title":"Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis","volume":"73","author":"Newton","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib532","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drup.2009.09.002","article-title":"Azole-resistance in aspergillus: proposed nomenclature and breakpoints","volume":"12","author":"Verweij","year":"2009","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2018.01.002_bib533","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.02226-12","article-title":"Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis","volume":"57","author":"Seyedmousavi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib534","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1128\/AAC.00833-13","article-title":"Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against cyp51 mutant isolates","volume":"57","author":"Lepak","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib535","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0163-4453(94)95941-2","article-title":"Treatment of invasive aspergillosis","volume":"28","author":"Denning","year":"1994","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib536","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(89)90475-0","article-title":"Treatment of invasive aspergillosis with itraconazole","volume":"86","author":"Denning","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib537","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/323020","article-title":"Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS","volume":"33","author":"Caillot","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib538","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1016\/j.ijid.2011.06.004","article-title":"Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients","volume":"15","author":"Kim","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib539","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12185-009-0296-3","article-title":"Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders","volume":"89","author":"Ueda","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib540","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.50.4.1570-1572.2006","article-title":"Voriconazole therapeutic drug monitoring","volume":"50","author":"Smith","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib541","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/jac\/dks258","article-title":"Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients","volume":"67","author":"Pieper","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib542","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.05219-11","article-title":"Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity","volume":"56","author":"Mitsani","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib543","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/jac\/dku023","article-title":"Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"69","author":"Siopi","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib544","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00663-08","article-title":"Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects","volume":"53","author":"Conte","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib545","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/infdis\/jit358","article-title":"Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis","volume":"208","author":"Campoli","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib546","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1128\/AAC.00637-11","article-title":"Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis","volume":"55","author":"Campoli","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib547","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1128\/AAC.03252-14","article-title":"Posaconazole concentrations in human tissues after allogeneic stem cell transplantation","volume":"58","author":"Blennow","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib548","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. Fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib549","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib550","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pupt.2008.09.001","article-title":"Tolerability of prophylactic aerosolized liposomal amphotericin-b and impact on pulmonary function: data from a randomized placebo-controlled trial","volume":"21","author":"Slobbe","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.cmi.2018.01.002_bib551","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.11936","article-title":"Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy","volume":"100","author":"Mattiuzzi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib552","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib553","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jinf.2016.06.011","article-title":"Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients","volume":"73","author":"Park","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib554","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijantimicag.2007.10.001","article-title":"Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: prophysome study","volume":"31","author":"Cordonnier","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.01.002_bib555","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial","volume":"17","author":"Penack","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cmi.2018.01.002_bib556","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/AAC.00155-13","article-title":"Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia","volume":"57","author":"Annino","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib557","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib558","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bmt.1705418","article-title":"A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients","volume":"38","author":"Oren","year":"2006","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib559","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dki440","article-title":"An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia","volume":"57","author":"Glasmacher","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib560","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib561","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/jac\/dkx133","article-title":"Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia","volume":"72","author":"Cornely","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib562","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib563","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib564","first-page":"1","article-title":"Isavuconazole shortens the QTC interval","volume":"00","author":"Mellinghoff","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib565","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/jac\/dkx027","article-title":"Isavuconazole: is there a need for a new antifungal?","volume":"72","author":"Cornely","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib566","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/tid.12454","article-title":"Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial","volume":"17","author":"Neofytos","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib567","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: a European organisation for research and treatment of cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib568","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"An eortc phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Viscoli","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib569","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1128\/AAC.05134-11","article-title":"Phase II dose escalation study of caspofungin for invasive aspergillosis","volume":"55","author":"Cornely","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib570","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1705143","article-title":"Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (hct) recipients with invasive aspergillosis (IA)","volume":"36","author":"Ito","year":"2005","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib571","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib572","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jinf.2006.03.003","article-title":"Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis","volume":"53","author":"Denning","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib573","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-3062.2008.00349.x","article-title":"Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"11","author":"Kontoyiannis","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib574","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (combistrat trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib575","first-page":"791","article-title":"Management of hemoptysis in invasive pulmonary aspergillosis","volume":"15","author":"Dohen-Becue","year":"1998","journal-title":"Rev Maladies Resp"},{"key":"10.1016\/j.cmi.2018.01.002_bib576","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib577","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine (Balt)"},{"key":"10.1016\/j.cmi.2018.01.002_bib578","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jac\/dkn409","article-title":"Posaconazole concentrations in the central nervous system","volume":"62","author":"R\u00fcping","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib579","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1227\/00006123-199504000-00032","article-title":"Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery\u2014case report and review of the literature","volume":"36","author":"Coleman","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cmi.2018.01.002_bib580","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1128\/AAC.49.12.4867-4875.2005","article-title":"Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (ambisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis","volume":"49","author":"Clemons","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib581","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1086\/515033","article-title":"An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis","volume":"27","author":"Ellis","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib582","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1439-0507.2007.01345.x","article-title":"Poor efficacy of amphotericin b-based therapy in cns aspergillosis","volume":"50","author":"Schwartz","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib583","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1086\/505969","article-title":"Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries","volume":"43","author":"Ullmann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib584","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/313498","article-title":"Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis","volume":"29","author":"Wingard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib585","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3324\/haematol.11811","article-title":"Improving outcomes of acute invasive aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole","volume":"93","author":"Girmenia","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib586","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/ceo.12055","article-title":"Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature","volume":"41","author":"Thurtell","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.cmi.2018.01.002_bib587","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S0022215107000722","article-title":"Advances in management of paranasal sinus aspergillosis","volume":"122","author":"Daudia","year":"2008","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.cmi.2018.01.002_bib588","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib589","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L amph\/ablc collaborative study group","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib590","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/514672","article-title":"Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. Amphotericin B in the empirical treatment of fever and neutropenia","volume":"27","author":"White","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib591","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/10428190802635500","article-title":"Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders","volume":"50","author":"Tamura","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cmi.2018.01.002_bib592","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2165\/11596540-000000000-00000","article-title":"Triazole antifungal agents in invasive fungal infections: a comparative review","volume":"71","author":"Lass-Florl","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2018.01.002_bib593","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib594","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(01)00364-3","article-title":"Nebulized amphotericin B prophylaxis for aspergillus infection in lung transplantation: study of risk factors","volume":"20","author":"Monforte","year":"2001","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib595","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-007-0376-3","article-title":"Aspergillus infection in lung transplant patients: incidence and prognosis","volume":"26","author":"Iversen","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib596","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077136","article-title":"Aspergillus fumigatus invasion increases with progressive airway ischemia","volume":"8","author":"Hsu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.01.002_bib597","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Aspergillus infections in lung transplant recipients: risk factors and outcome","volume":"11","author":"Sole","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib598","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.healun.2008.03.010","article-title":"Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation","volume":"27","author":"Danziger-Isakov","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib599","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-3062.2006.00136.x","article-title":"Igg monitoring to identify the risk for development of infection in heart transplant recipients","volume":"8","author":"Sarmiento","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib600","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s10096-003-0960-0","article-title":"Voriconazole in the treatment of invasive mold infections in transplant recipients","volume":"22","author":"Fortun","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib601","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk factors for invasive fungal infections complicating orthotopic liver transplantation","volume":"170","author":"Collins","year":"1994","journal-title":"J Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.cmi.2018.01.002_bib602","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1111\/j.1600-6143.2009.02910.x","article-title":"Invasive aspergillosis in solid organ transplant recipients","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib603","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/lt.20756","article-title":"Invasive aspergillosis in the recipients of liver retransplantation","volume":"12","author":"Singh","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib604","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: outcomes and risk factors revisited in the meld era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib605","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/cc9402","article-title":"Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study","volume":"15","author":"He","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib606","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2018.01.002_bib607","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1078\/1438-4639-00106","article-title":"Role of increased environmental aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit","volume":"204","author":"Kistemann","year":"2002","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.cmi.2018.01.002_bib608","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.burns.2008.04.007","article-title":"Incidence of systemic fungal infection and related mortality following severe burns","volume":"34","author":"Murray","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.cmi.2018.01.002_bib609","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11046-014-9740-x","article-title":"Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis","volume":"177","author":"Lahmer","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2018.01.002_bib610","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/BCR.0b013e31815f6ecb","article-title":"Positive fungal cultures in burn patients: a multicenter review","volume":"29","author":"Ballard","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.cmi.2018.01.002_bib611","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/01.sla.0000256914.16754.80","article-title":"Fungal wound infection (not colonization) is independently associated with mortality in burn patients","volume":"245","author":"Horvath","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.cmi.2018.01.002_bib612","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/cc11443","article-title":"Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study","volume":"16","author":"He","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.01.002_bib613","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2277-9175.125851","article-title":"Galactomannan antigen assay from bronchoalveolar lavage fluid in diagnosis of invasive pulmonary aspergillosis in intensive care units patients","volume":"3","author":"Khorvash","year":"2014","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.cmi.2018.01.002_bib614","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JCM.00478-16","article-title":"Detection of Aspergillus fumigatus in blood samples from critically ill patients in intensive care units by use of the septifast assay","volume":"54","author":"Steinmann","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1469-0691.2009.02736.x","article-title":"Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis","volume":"15","author":"Westh","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib616","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib617","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejrad.2013.03.026","article-title":"High-resolution computed tomographic findings of Aspergillus infection in lung transplant patients","volume":"83","author":"Gazzoni","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib618","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.01183-10","article-title":"The (1,3)\u03b2-d-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation","volume":"48","author":"Alexander","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.01.002_bib619","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.tp.0000263992.41003.33","article-title":"Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients","volume":"83","author":"Husain","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib620","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/jac\/dkv449","article-title":"Voriconazole and cobicistat-boosted antiretroviral salvage regimen co-administration to treat invasive aspergillosis in an HIV-infected patient","volume":"71","author":"Ambrosioni","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib621","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1399-0012.2000.140402.x","article-title":"Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment","volume":"14","author":"Utili","year":"2000","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib622","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.healun.2003.10.014","article-title":"Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation","volume":"24","author":"Wieland","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib623","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.transproceed.2007.05.012","article-title":"Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients","volume":"39","author":"Veroux","year":"2007","journal-title":"Transpl Proc"},{"key":"10.1016\/j.cmi.2018.01.002_bib624","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1097\/01.TP.0000089109.42239.75","article-title":"Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy","volume":"76","author":"Baden","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib625","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0b013e3181f995ea","article-title":"Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (ABELCET; ABLC) in lung transplant recipients","volume":"90","author":"Husain","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib626","doi-asserted-by":"crossref","first-page":"238","DOI":"10.12659\/AOT.883921","article-title":"Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient","volume":"18","author":"Mucha","year":"2013","journal-title":"Ann Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib627","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/ajt.13837","article-title":"Clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study","volume":"16","author":"Lopez-Medrano","year":"2016","journal-title":"Am J Transpl"},{"issue":"Suppl. 6","key":"10.1016\/j.cmi.2018.01.002_bib628","doi-asserted-by":"crossref","first-page":"S392","DOI":"10.1086\/429333","article-title":"Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients","volume":"40","author":"Chandrasekar","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib629","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1080\/13693780400025237","article-title":"Aspergillosis in the clear outcomes trial: working toward a real-world clinical perspective","volume":"43","author":"Kleinberg","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2018.01.002_bib630","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/375219","article-title":"Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib631","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2007.10.002","article-title":"Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation","volume":"27","author":"Groetzner","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib632","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3062.2009.00490.x","article-title":"Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study","volume":"12","author":"Winkler","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib633","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-10-182","article-title":"Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry","volume":"10","author":"Maertens","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib634","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1111\/j.1439-0507.2009.01829.x","article-title":"Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin","volume":"54","author":"Walter","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib635","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1600-6143.2007.01882.x","article-title":"Pneumonia after lung transplantation in the resitra cohort: a multicenter prospective study","volume":"7","author":"Aguilar-Guisado","year":"2007","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib636","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tid.12071","article-title":"Preemptive treatment with voriconazole in lung transplant recipients","volume":"15","author":"Neoh","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib637","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib638","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib639","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.healun.2012.11.013","article-title":"Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant","volume":"32","author":"Monforte","year":"2013","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib640","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.transproceed.2008.09.020","article-title":"Efficiency and safety of inhaled amphotericin B lipid complex (ABELCET) in the prophylaxis of invasive fungal infections following lung transplantation","volume":"40","author":"Borro","year":"2008","journal-title":"Transpl Proc"},{"key":"10.1016\/j.cmi.2018.01.002_bib641","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/cit940","article-title":"Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients","volume":"58","author":"Williams","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.cmi.2018.01.002_bib642","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1086\/376527","article-title":"Invasive aspergillosis in the setting of cardiac transplantation","volume":"37","author":"Montoya","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib643","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.transproceed.2010.08.013","article-title":"Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation","volume":"42","author":"Paniagua Martin","year":"2010","journal-title":"Transpl Proc"},{"key":"10.1016\/j.cmi.2018.01.002_bib644","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00007890-200104150-00016","article-title":"Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy","volume":"71","author":"Singh","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib645","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.transproceed.2005.10.043","article-title":"Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients","volume":"37","author":"Castroagudin","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1016\/j.cmi.2018.01.002_bib646","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/lt.21331","article-title":"Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients","volume":"13","author":"Reed","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib647","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/TP.0b013e3181932e76","article-title":"Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.01.002_bib648","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Int Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib649","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2003-07-2512","article-title":"Cyclophosphamide metabolism is affected by azole antifungals","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib650","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib651","first-page":"56","volume":"vol. 101","author":"Prentice","year":"1999"},{"key":"10.1016\/j.cmi.2018.01.002_bib652","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/AAC.44.7.1887-1893.2000","article-title":"Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B","volume":"44","author":"Harousseau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib653","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib654","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.42.2.404","article-title":"Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children","volume":"42","author":"de Repentigny","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib655","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1128\/AAC.46.8.2554-2563.2002","article-title":"Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis","volume":"46","author":"Groll","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib656","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1702023","article-title":"Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders","volume":"24","author":"Foot","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib657","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00520-006-0125-7","article-title":"Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants","volume":"15","author":"Simon","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib658","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2011.051995","article-title":"Comparative clinical effectiveness of prophylactic voriconazole\/posaconazole to fluconazole\/itraconazole in patients with acute myeloid leukemia\/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period","volume":"97","author":"Ananda-Rajah","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib659","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e328359a56e","article-title":"Making sense of posaconazole therapeutic drug monitoring: a practical approach","volume":"25","author":"Ananda-Rajah","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib660","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1592\/phco.27.12.1627","article-title":"Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease","volume":"27","author":"Krishna","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2018.01.002_bib661","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e3182195808","article-title":"A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease","volume":"30","author":"Welzen","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib662","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2334-12-263","article-title":"Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation","volume":"12","author":"D\u00f6ring","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib663","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10096-010-0957-4","article-title":"Posaconazole salvage treatment in paediatric patients: a multicentre survey","volume":"29","author":"Lehrnbecher","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib664","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/INF.0000000000000963","article-title":"Pharmacokinetics of posaconazole oral suspension in children dosed according to body surface area","volume":"35","author":"Vanstraelen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib665","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00520-009-0783-3","article-title":"Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome","volume":"19","author":"Mattiuzzi","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib666","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.23388","article-title":"The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole","volume":"88","author":"Barreto","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib667","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib668","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.00751-08","article-title":"Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies","volume":"53","author":"Karlsson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib669","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1128\/AAC.05010-11","article-title":"Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults","volume":"55","author":"Driscoll","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib670","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1128\/AAC.00531-11","article-title":"Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults","volume":"55","author":"Driscoll","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib671","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bmt.2011.111","article-title":"Voriconazole as primary antifungal prophylaxis in children undergoing allo-sct","volume":"47","author":"Molina","year":"2012","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib672","first-page":"1495","article-title":"Prophylactic use of liposomal amphotericin B (ambisome) against fungal infections: a randomized trial in bone marrow transplant recipients","volume":"25","author":"Tollemar","year":"1993","journal-title":"Transpl Proc"},{"key":"10.1016\/j.cmi.2018.01.002_bib673","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib674","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (ambisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib675","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.50.3.935-942.2006","article-title":"Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases","volume":"50","author":"Hong","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. B","key":"10.1016\/j.cmi.2018.01.002_bib676","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/28.suppl_B.73","article-title":"Efficacy of amphotericin B encapsulated in liposomes (ambisome) in the treatment of invasive fungal infections in immunocompromised patients","volume":"28","author":"Ringden","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib677","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/dkp196","article-title":"Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation","volume":"64","author":"Kolve","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib678","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.bbmt.2012.03.014","article-title":"Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant","volume":"18","author":"Huang","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib679","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib680","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1128\/AAC.00398-07","article-title":"Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing","volume":"51","author":"Hope","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib681","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/INF.0b013e3182127eaf","article-title":"Safety of micafungin in pediatric clinical trials","volume":"30","author":"Arrieta","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib682","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.bbmt.2010.05.002","article-title":"Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study","volume":"16","author":"Mehta","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib683","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/INF.0b013e3181f13b23","article-title":"Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France","volume":"30","author":"Beaute","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib684","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3476(05)82023-2","article-title":"Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease","volume":"125","author":"Mouy","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.cmi.2018.01.002_bib685","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/AAC.00896-10","article-title":"Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children","volume":"54","author":"Walsh","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib686","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/INF.0b013e31824acc33","article-title":"Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children","volume":"31","author":"Doby","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib687","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jac\/dkr517","article-title":"Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study","volume":"67","author":"Soler-Palacin","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib688","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/AAC.01540-12","article-title":"Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients","volume":"57","author":"Bartelink","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib689","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-5173(02)00066-2","article-title":"A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates","volume":"238","author":"Kotwani","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cmi.2018.01.002_bib690","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1469-0691.2011.03483.x","article-title":"Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients","volume":"17","author":"Bochennek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib691","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1128\/AAC.00425-10","article-title":"Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients","volume":"54","author":"Groll","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib692","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s10156-011-0357-4","article-title":"Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children","volume":"18","author":"Sunakawa","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib693","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib694","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/AAC.01027-08","article-title":"Pharmacokinetics and safety of caspofungin in older infants and toddlers","volume":"53","author":"Neely","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib695","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2334-7-28","article-title":"Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients","volume":"7","author":"Cesaro","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib696","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/INF.0b013e3181af5a15","article-title":"Safety experience with caspofungin in pediatric patients","volume":"28","author":"Zaoutis","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib697","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.2008-1158","article-title":"A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2018.01.002_bib698","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijantimicag.2011.07.008","article-title":"Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report","volume":"38","author":"Ngai","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2018.01.002_bib699","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.earlhumdev.2012.07.002","article-title":"Response to \"is liposomal amphotericin B really safety in neonates?\"","volume":"89","author":"Manzoni","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.cmi.2018.01.002_bib700","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.earlhumdev.2012.07.015","article-title":"Is liposomal amphotericin B really safety in neonates?","volume":"89","author":"Karadag-Oncel","year":"2013","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.cmi.2018.01.002_bib701","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00006454-199802000-00013","article-title":"Liposomal amphotericin B treatment for neonatal fungal infections","volume":"17","author":"Scarcella","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.01.002_bib702","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-003-0993-4","article-title":"High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates","volume":"22","author":"Juster-Reicher","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib703","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3324\/haematol.2009.020073","article-title":"Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study","volume":"95","author":"Cordonnier","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2018.01.002_bib704","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/tid.12068","article-title":"Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients","volume":"15","author":"Liu","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib705","series-title":"Gemeinsame Jahrestagung der Deutschen, \u00d6sterreichischen und Schweizerichen GHO","article-title":"Epidemiology of Aspergillus spp. At the university hospital of cologne: molecular typing of environmental and clinical isolates","author":"Gerlach","year":"2008"},{"key":"10.1016\/j.cmi.2018.01.002_bib706","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jac\/dkm521","article-title":"Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients","volume":"61","author":"Allinson","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib707","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bmt.1705720","article-title":"Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and\/or systemic fungal infection","volume":"40","author":"de Fabritiis","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib708","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2006-03-008706","volume":"108","author":"Martino","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.01.002_bib709","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000083447","article-title":"Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B","volume":"113","author":"Kruger","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib710","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1705655","article-title":"Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia","volume":"39","author":"Nosari","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2018.01.002_bib711","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.mlg.0000245941.03953.5d","article-title":"Endoscopic surgery for sinonasal invasive aspergillosis in bone marrow transplantation patients","volume":"117","author":"Eliashar","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.cmi.2018.01.002_bib712","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/pbc.21089","article-title":"Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patients","volume":"49","author":"Cesaro","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib713","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1378\/chest.126.6.1783","article-title":"Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia","volume":"126","author":"Matt","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2018.01.002_bib714","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1164\/ajrccm.158.3.9801056","article-title":"Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases","volume":"158","author":"Reichenberger","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib715","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib716","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib717","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0609.2005.00500.x","article-title":"Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies","volume":"75","author":"Candoni","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib718","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.1995.00430100129015","article-title":"Liposomal amphotericin B (ambisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data","volume":"155","author":"Ng","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib719","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/cncr.23311","article-title":"Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib720","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib721","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/clinids\/21.5.1145","article-title":"The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses","volume":"21","author":"Oppenheim","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib722","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000048472","article-title":"Safety and efficacy of amphotericin B colloidal dispersion. An overview","volume":"45","author":"Herbrecht","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cmi.2018.01.002_bib723","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.21615","article-title":"Efficacy of caspofungin against invasive candida or invasive Aspergillus infections in neutropenic patients","volume":"106","author":"Betts","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2018.01.002_bib724","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2047-783X-17-7","article-title":"Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry","volume":"17","author":"Egerer","year":"2012","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cmi.2018.01.002_bib725","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10096-010-1013-0","article-title":"Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort","volume":"29","author":"Hiemenz","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib726","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jinf.2004.05.011","article-title":"Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study","volume":"50","author":"Kartsonis","year":"2005","journal-title":"J Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.cmi.2018.01.002_bib727","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1439-0507.2007.01377.x","article-title":"Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A","volume":"50","author":"Morrissey","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib728","first-page":"274","article-title":"Efficacy and safety of caspofungin in critically ill patients. Procas study","volume":"25","author":"Leon-Gil","year":"2012","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.cmi.2018.01.002_bib729","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jinf.2014.01.007","article-title":"Micafungin for the treatment of invasive aspergillosis","volume":"68","author":"Enoch","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2018.01.002_bib730","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/jac\/dkn401","article-title":"Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment","volume":"62","author":"Hachem","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.01.002_bib731","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/myc.12023","article-title":"Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis","volume":"56","author":"Heinz","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib732","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000069281","article-title":"Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis","volume":"109","author":"Caillot","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cmi.2018.01.002_bib733","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1439-0507.2002.00738.x","article-title":"Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital","volume":"45","author":"Chakrabarti","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2018.01.002_bib734","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7883\/yoken.66.312","article-title":"A case series of chronic necrotizing pulmonary aspergillosis and a new proposal","volume":"66","author":"Tashiro","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.cmi.2018.01.002_bib735","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0190-9622(90)70263-H","article-title":"Itraconazole therapy in aspergillosis: study in 49 patients","volume":"23","author":"Dupont","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cmi.2018.01.002_bib736","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.11.028","article-title":"Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis","volume":"119","author":"Sambatakou","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2018.01.002_bib737","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s15010-012-0322-x","article-title":"Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan","volume":"40","author":"Saito","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2018.01.002_bib738","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and safety of posaconazole for chronic pulmonary aspergillosis","volume":"51","author":"Felton","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1830051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1830051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:04:54Z","timestamp":1719875094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1830051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":736,"alternative-id":["S1198743X1830051X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.01.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}